Chicago, IL – February 21, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Broadcom Inc. AVGO, Thermo Fisher Scientific Inc. TMO, Aon plc AON and Massimo Group MAMO.
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for Broadcom, Thermo Fisher and Aon
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Thermo Fisher Scientific Inc. and Aon plc, as well as a micro-cap stock, Massimo Group.
These research reports have been hand-picked from roughly 70 reports published by our analyst team today. You can see all of today’s research reports here >>>
Ahead of Wall Street
The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.
You can read today's AWS here >>> Steady Jobless Claims, Good Philly Fed, Healthy Q4 Earnings
Today's Featured Research Reports
Broadcom’s shares have outperformed the Zacks Electronics - Semiconductors industry over the past year (+85.3% vs. +47.6%). The Zacks analyst believes that the company is benefiting from strong demand for its networking products and custom AI accelerators (XPUs). Broadcom’s expanding AI portfolio, along with a rich partner base, reflects solid top-line growth potential.
However, a challenging macroeconomic environment and high debt level are major concerns.
(You can read the full research report on Broadcom here >>>)
Thermo Fisher’s shares have underperformed the Zacks Medical – Instruments industry over the past year (-4.0% vs. +4.8%). The Zacks analyst believes that volatile macroeconomic uncertainties can dent Thermo Fisher’s operations. The continuous decline in COVID testing-related demand also adds to the worry.
Yet, the company is braving the ongoing tough economic conditions by utilizing the PPI Business System. Several recent product launches, including a Thermo Scientific Iliad scanning transmission electron microscope and new additions to the Gibco CTS Detachable Dynabeads platform have aided. Its continuous efforts to prioritize its partnership with customers to drive innovation and improve patient care bode well.
(You can read the full research report on Thermo Fisher here >>>)
Shares of Aon have outperformed the Zacks Insurance – Brokerage industry over the past six months (+16.8% vs. +8.4%). Per the Zacks analyst, the company’s bottom line has been growing due to strategic initiatives and strong fundamentals, which have enhanced its capabilities and made it one of the largest insurance brokers.
However, long-term debt has been continuously increasing since 2014. Growing interest expenses are a concern. Its financial results are sensitive to foreign exchange rate fluctuations.
(You can read the full research report on Aon here >>>)
Massimos’ shares have underperformed the Zacks Leisure and Recreation Products industry over the last six months (-10.1% vs. +33.3%). The Zacks analyst believes that the company faces headwinds, including supply chain disruptions due to its reliance on global suppliers, and rising material costs from inflationary pressures. Reliance on a concentrated customer base poses financial risks.
Yet, new product launches, automation investments, and strategic partnerships have benefited the company. Strategic deals with Tractor Supply and Armlogi enhance retail and operational efficiency. Massimo is also entering the EV sector with eco-friendly UTVs and ATVs, aligning with consumer demand for sustainability.
(You can read the full research report on Massimo here >>>)
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
